par D'Alto, Michele;Romeo, Emanuele;Argiento, Paola;Santoro, Giuseppe;Sarubbi, Berardo;Gaio, Giampiero;Melot, Christian
;Russo, Maria Giovanna;Naeije, Robert
;Calabrò, Raffaele
Référence Heart, 96, 18, page (1475-1479)
Publication Publié, 2010-09


Référence Heart, 96, 18, page (1475-1479)
Publication Publié, 2010-09
Article révisé par les pairs
Résumé : | Vasoreactivity testing is recommended in the management of pulmonary arterial hypertension (PAH), but its clinical relevance in congenital heart disease (CHD)-associated PAH has not been established. |